Precision oncology: Present and future in breast cancer

CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG

The role of the workforce in implementing Choosing Wisely in cancer care

African oncologists interaction with pharmaceutical industry

Choosing Wisely to mitigate financial toxicity in cancer care in Africa

Haemopathy burden in the National Cancer Center of Cambodia

Time toxicity: opportunity costs of low value cancer treatment

Choosing wisely in multiple myeloma

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery

Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity